• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

buyouts

Assortment of tools laid out on wooden background
Biotech

Repare nails down XenoTherapeutics buyout

After laying off staff and partnering away an asset, the precision oncology outfit has agreed to be acquired by nonprofit biotech XenoTherapeutics.
Darren Incorvaia Nov 17, 2025 12:12pm
Painting over a mural with blue paint

Painted into a corner, Mural agrees to Xoma buyout

Aug 20, 2025 10:28am
blocks with checks and crosses

Concentra scoops up near-defunct Allakos

Apr 2, 2025 5:05pm
invest benjamin franklin dollars bills

Agiliti to go private in $2.5B buyout deal

Feb 27, 2024 11:19am
money private equity venture capital investment cash dollar sign investor

Permira takes CRO Ergomed private in £703M buyout deal

Sep 7, 2023 5:00am
poison pill toxic poison

Quince adopts 'poison pill' to fend off buyout, stock purchases

Apr 6, 2023 8:24am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings